Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 2016; 116(04): 590-591
DOI: 10.1160/TH16-08-0602

Invited Editorial Focus

Schattauer GmbH

Authors

Jeffrey S. Ginsberg

¹Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Mark A. Crowther

¹Department of Medicine, McMaster University, Hamilton, Ontario, Canada

²Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

Received: 03 August 2016

Accepted: 03 August 2016

Publication Date:
20 November 2017 (online)

References
1 Hall JG, Pauli RM, Wilson KM.. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122-140.

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Wainwright H, Beighton P.. Warfarin embryopathy: fetal manifestations. Virchows Arch 2010; 457: 735-739.

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Ginsberg JS, Hirsh J, Turner DC. et al. Risks to the fetus of anticoagulant therapy during pregnancy. [Review]. Thromb Haemost 1989; 61: 197-203.

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar
4 Weitz JI.. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698.

Reference Link Ris
Crossref PubMed Search in Google Scholar
5 Agency EM.. CHMP Assessment report for Xarelto [PDF]. London: European Medicines Agency; 2016. [Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000944/WC500057122.pdf

Reference Link Ris
6 Beyer-Westendorf J, Michalski F, Tittl L. et al Pregnancy outcome in patients exposed to direct oral anticoagulants – and the challenge of event reporting. Thromb Haemost 2016; 116: 651-658.

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar